首页> 外文期刊>Pathology International >Ductal adenoma of the breast: immunohistochemistry of two cases.
【24h】

Ductal adenoma of the breast: immunohistochemistry of two cases.

机译:乳腺导管腺瘤:免疫组化2例。

获取原文
获取原文并翻译 | 示例
           

摘要

The author reports herein two cases of ductal adenoma of the breast with an emphasis on immunohistochemistry. Both cases (patient 1, 58-year-old woman; patient 2, 78-year-old woman) were clinically suspected as carcinoma, and core biopsies were 'indeterminate' or 'suspicious for malignancy'. Excisional biopsy and wide excision were performed. Histologically, both cases were ductal adenomas composed of ductal epithelial cells and myoepithelial cells. Patient 1 had extensive apocrine metaplasia. Immunohistochemically, myoepithelial cells were noted in both cases; cytokeratin (CK) 14 and p63 were the most reliable myoepithelial markers, followed by CD10, alpha-smooth muscle actin and S100 protein. CK profile was as follows: positive expression of CK5/6, CK18, CK19, and high-molecular-weight CK, and negative expression of CK20. This CK profile was the same as that of non-tumorous ducts, suggesting that the CK profile does not alter in tumorigenesis. The tumor cells expressed p53 protein (case 1, positive cell percentage 5%; case 2, 7%), c-erbB2 (HER2eu, 76%, 64%), CEA (5%, 0%), estrogen receptor (33%, 84%), but were negative for progesterone receptor. Ki-67 labeling was 5% and 3%, respectively. MUC apomucin expression was as follows: MUC1, 92%, 100%; MUC2, 0%, 0%; MUC5AC, 0%, 0%; and MUC6, 5%, 0%. Non-tumorous ducts expressed MUC1, but were negative for MUC2, MUC5AC and MUC6.
机译:作者在此报道了乳腺导管腺瘤的两例,重点是免疫组织化学。两种病例(患者1,58岁的妇女;患者2,78岁的妇女)在临床上都被怀疑是癌,并且核心活检标本“不确定”或“可疑为恶性肿瘤”。进行切除活检和广泛切除。从组织学上讲,这两种情况都是由导管上皮细胞和肌上皮细胞组成的导管腺瘤。患者1具有广泛的顶泌化生。在免疫组织化学中,在两种情况下均注意到肌上皮细胞。细胞角蛋白(CK)14和p63是最可靠的肌上皮标志物,其次是CD10,α平滑肌肌动蛋白和S100蛋白。 CK概况如下:CK5 / 6,CK18,CK19和高分子量CK的阳性表达,而CK20的阴性表达。该CK谱与非肿瘤导管的CK谱相同,表明CK谱在肿瘤发生中没有改变。肿瘤细胞表达p53蛋白(病例1,阳性细胞百分比5%;病例2,7%),c-erbB2(HER2 / neu,76%,64%),CEA(5%,0%),雌激素受体( 33%,84%),但孕激素受体阴性。 Ki-67标记分别为5%和3%。 MUC载脂蛋白表达如下:MUC1,92%,100%;和MUC2,0%,0%; MUC5AC,0%,0%;和MUC6,5%,0%。非肿瘤导管表达MUC1,但MUC2,MUC5AC和MUC6阴性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号